Clinical Trial Update: Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating micro-dosing buprenorphine/naloxone for postoperative pain management in opioid-tolerant patients has been withdrawn. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Post-operative Pain | Phase 4 | Status: WITHDRAWN